From: Daily antibiotic cost of nosocomial infections in a Turkish university hospital
Pathogens | No. | Overall daily cost (US$) | Range of daily cost per pathogen (US$) | Median (US$) |
---|---|---|---|---|
Pseudomonas aeruginosa | 60 | 5567,06 | 17,98–204,74 | 100,04 |
Acinetobacter spp | 36 | 4951,06 | 17,98–359,28 | 92,47 |
Stenotrophomonas maltophilia | 4 | 310,99 | 31,31–100,04 | 89,82 |
Klebsiella spp | 37 | 3104,22 | 10,02–179,64 | 79,6 |
Enterobacter spp | 10 | 961,79 | 60,42–139,08 | 77,28 |
Escherichia coli | 23 | 1652,57 | 10,02–179,64 | 60,41 |
Proteus spp | 3 | 49,04 | 13,24–49,04 | 49,04 |
Staphylococcus aureus | ||||
Methicillin-susceptible (MS) | 6 | 476,22 | 10,02–142,2 | 74,52 |
Methicillin-resistance (MR) | 15 | 1188,1 | 35,88–142,2 | 71,1 |
CoNS* | ||||
MS-CoNS | 1 | 49,64 | 16,34–49,64 | 49,64 |
MR-CoNS | 3 | 148,92 | 17,52–49,64 | 49,64 |
Enterococcus spp | 16 | 1141,25 | 32,29–142,2 | 49,64 |
Candida spp | 21 | 235,52 | 8,56–38,64 | 8,56 |
No pathogen identified | 27 | 3166,75 | 10,02–359,28 | 114,6 |